Hunan Kaiyuan Pharmaceutical

Hunan Kaiyuan Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Changsha, China, specializing in the research, development, and manufacturing of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1993, the company operates modern, GMP-certified production facilities capable of producing tablets, capsules, and granules at scale. Its product portfolio is primarily focused on high-prevalence therapeutic areas, including cardiovascular health, anti-infectives, and metabolic disorders. Key commercial products include Amlodipine Besylate for hypertension and various macrolide antibiotics such as Azithromycin and Clarithromycin. The company serves a broad domestic market in China and has expanded its reach through international exports of both APIs and finished drugs. Hunan Kaiyuan emphasizes stringent quality management systems and continuous technological improvement to maintain its competitive position in the generic pharmaceutical industry.